AN#169 Diagnostic method for serological testing
of Covid-19 antibodies

Application Note #169


Figure 1.
Schematic representation of Covid-19 diagnostic method: SARS-CoV-2 specific antibodies from human serum are detected on MP-SPR sensor functionalized with virus proteins.

Considering the indisputable need for Covid-19 related diagnostic tools, we have developed a dedicated serological testing method based on MP-SPR technology. The combination of MP-SPR instrument and optimized sensor format functionalized with virus proteins enabled rapid detection of SARS-CoV-2 antigen-specific antibodies in human serum. The measurement accuracy has been proven with seropositive patient samples and validated with certified reference serum materials. As alternative to currently existing methods, BioNavis will launch a Covid-19 diagnostic kit to be used for immunity surveys across populations and screening the efficacy of treatments developed against SARS-CoV-2.

Recommended instrument for this application:

200_otso_small.jpg 400_KONTIO_LOGO_24012019_cropped.jpg 210_vasa_small.jpg 410A_KAURIS_instrument.jpg  220A_naali_small.jpg 420_ilves_small.jpg
200 OTSO 400 KONTIO 210A VASA  410A KAURIS  220A NAALI 420A ILVES 
                          green-tick.png   green-tick.png 

Further reading

  • Take a look at AN#162 to read more about assay development and AN#155 for protein interaction studies.
  • If you are interested to learn about our regenerable avidin kit, check AN#166 and AN#168.

  • Do you want to find out how to calculate kinetics and affinity out of MP-SPR measurements? Click here.

  • Do you want to see MP-SPR instruments comparison? Click here.

DOWNLOAD APPLICATION NOTE IN PDF


Back to all Application Notes